PB2706: NO DIFFERENCE IN SURVIVAL OUTCOMES BETWEEN IMMIGRANTS AND DANISH-BORN CITIZENS WITH A HEMATOLOGICAL MALIGNANCY: A NATIONWIDE, POPULATION-BASED REGISTER STUDY by Joachim Baech, Lasse Jakobsen, Marianne Severinsen, Mikkel Runason Simonsen, Henrik Frederiksen, Carsten Niemann, Judit Jørgensen, Søren Johnsen, Tarec El-Galaly

Get full text

Analysis of temporal survival trends: considerations and best practice by Mikkel Runason Simonsen, Lars Klingen Gjærde, Lars Hernández Nielsen, Jan Brink Valentin, Rasmus Plenge Waagepetersen, Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen

Get full text

Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma by Jelena Jelicic, Karen Juul‐Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al‐Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen

Get full text

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up by Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson, Øystein Fluge, Sirpa Leppä, Bjørn Østenstad, Alexander Fosså, Mikael Eriksson, Tarec El-Galaly, Hanne Kuitunen, Karin Papworth, Maria Ljungqvist, Martin B. Pedersen, Marjukka Pollari

Get full text